Top Markets
#1 Official Trump Official Trump +51.06%
#2 Zama Zama +26.16%
#3 Mubarak Mubarak +24.39%
#4 Movement Movement +24.23%
#5 Melania Meme Melania Meme +22.69%
#6 Pearl Pearl +21.13%
#7 Wrapped POL Wrapped POL +19.04%
#8 EXOD EXOD +18.93%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.70%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +17.69%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

002118
Rank in Stocks #23825
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is a Chinese enterprise... Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is a Chinese enterprise dedicated to the research, development, manufacturing, and distribution of both traditional Chinese medicines and advanced gene sequencing equipment. Its pharmaceutical offerings are diverse, encompassing ginseng-based medications, prescription drugs, and over-the-counter (OTC) remedies. These products are available in a broad spectrum of dosage forms, including pills, tablets, hard and soft capsules, various oral liquids (such as solutions and mixtures), granules, and lozenges. The company was established in 1998 and operates from its headquarters in Changchun, China.
Share Price
$0.05361814
Last synced: 2023-06-15
Market Cap
$68.67M
Change (1 day)
-1.51%
Change (1 year)
0.00%
Country
CN
Trade Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118)

Category

Healthcare
Revenue for Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118)
Revenue in Aug 2026 TTM: 0
According to Jilin Zixin Pharmaceutical Industrial Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jilin Zixin Pharmaceutical Industrial Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN